Cellular Target Of Leprosy, Deadly Viruses Found

December 11, 1998--A cell-surface protein whose absence causes a fatal form of muscular dystrophy is also the target that the leprosy bacterium uses to latch onto cells before invading them. And in an equally surprising twist, it also appears that two hemorrhagic fever viruses gain entry to cells via the same molecular handle.

These discoveries could lead to new drugs to prevent nerve damage in leprosy patients and to thwart infection by the deadly viruses, according to two research teams that reported these findings in two articles in the December 11, 1998, issue of the journal Science. One team included scientists from the Howard Hughes Medical Institute (HHMI) at the University of Iowa and The Rockefeller University in New York. The second team included scientists from The Scripps Research Institute and the same HHMI group.

About 800,000 people worldwide suffer from leprosy, which is caused by the bacterium Mycobacterium leprae. Hemorrhagic fever viruses infect about 250,000 people and cause 5,000 deaths worldwide each year.

The molecular handle used by the bacterium and viruses is called dystroglycan (DG). It belongs to a common family of molecules called glycoproteins, which are often embedded in cell membranes.

DG is the cell-surface component of a group of associated proteins known as the dystrophin-glycoprotein complex. Originally identified by HHMI investigator Kevin Campbell and his colleagues, this complex nestles in the membrane of cells throughout the body, acting as a receptor for a protein called laminin. Laminin, in turn, links cells to the scaffolding, or matrix, that helps knit together the body's tissues.

When the complex is absent, cells do not interconnect properly with the matrix outside the cell. Duchenne muscular dystrophy, a fatal inherited disease, is caused by a genetic lack of dystrophin. The muscle cells of people with

Contact: Jim Keeley
Howard Hughes Medical Institute

Page: 1 2 3

Related biology news :

1. Cellular problems found behind complex obesity syndrome
2. Cellular fat sensor slows heart disease
3. Cellular problem discovered behind syndrome of obesity, learning disabilities
4. Clock cues: Cellular sensing, metabolism research wins Amersham Biosciences and Science Prize
5. Cellular pathway includes a clock that steers gene activity
6. Cellular organelle evolved repeatedly
7. Cellular membrane changes associated with acclimation to cold
8. Cellular espionage at play in post-menopausal osteoporosis
9. Dual Control Strategy Assures Accurate Cellular Marching Orders, But A Pathogenic Microbe Can Hijack The System
10. UC Davis Researchers Get First Look At A Working Cellular Motor
11. New Insights On Sequence of Cell Death After Brain Injury: Understanding Cellular Events After Brain Trauma Could Lead To Better Therapies

Post Your Comments:

(Date:7/2/2020)... CITY, Calif. (PRWEB) , ... July 01, 2020 ... ... biotech company, presented its phase 1a findings of Neihulizumab, a biologic for the ... conference in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for biopharmaceutical R&D, today announced that it has entered into a multi-year ... antibodies (Multiclonics®), to support their translational and clinical research strategy to discover ...
(Date:6/23/2020)... ... 23, 2020 , ... First Aid Africa, a Scottish charity ... and manufacturer of innovative portable renewable energy equipment, have announced the success of ... COVID-19 pandemic in Zambia. , One of Renovagen’s FAST FOLD portable solar power ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... ... radar transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and ... can drive one or two switches in a push-pull configuration; yielding fast fall ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... for the life sciences industry, today announced the release of its signature ... for Medical Science Liaisons (MSLs) and other field medical professionals. , ...
(Date:7/18/2020)... ... 17, 2020 , ... dicentra , a leading Contract ... industries, is pleased to announce that Charles Galea has joined its clinical trials ... is an accomplished and results-driven sales executive with over 10 years of expertise ...
(Date:7/7/2020)... DIEGO (PRWEB) , ... July 06, 2020 , ... R3 ... new program featuring up to 200 million stem cells. Depending on the patient's condition, ... seniors in the US will die having some form of Alzheimers dementia, and the ...
Breaking Biology Technology:
Cached News: